Printed From BioPortfolio.com

MorphoSys to Fast-Track Cancer Combo with Breakthrough Designation

09:29 EDT 24 Oct 2017 | Labiotech.eu

The FDA has given the German biotech’s blood cancer antibody combination Breakthrough Therapy Designation on the back of good preliminary Phase II results. MorphoSys is one of Germany’s biggest biotechs, which hopes to generate optimized antibodies for the treatment of serious ...

This awesome article MorphoSys to Fast-Track Cancer Combo with Breakthrough Designation appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: MorphoSys to Fast-Track Cancer Combo with Breakthrough Designation

More From BioPortfolio on "MorphoSys to Fast-Track Cancer Combo with Breakthrough Designation"

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

News Quicklinks

Search Biotech, Medical and Healthcare News

Biotech News by Article Type

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches